- New CRO Partner Joins BioClinica Certified Partner Program -
NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced it has established a strategic partnership with Symbiance Inc., a specialty contract research organization (CRO) based in Princeton Junction, New Jersey. Symbiance concentrates in therapeutic areas relevant to pharmaceutical and biotechnology companies with particular focus in oncology and CNS.
"With their therapeutic expertise and knowledge of the clinical trial space, Symbiance is an excellent partner for BioClinica's offerings. I am confident in the added value this partnership will bring to our mutual clients," said Peter Benton, President of eClinical Solutions for BioClinica.
Symbiance began operations in 1990 to provide clear, precise and timely solutions for the data needs of clinical trial professionals. As a leading contract research organization with proven expertise in delivering innovative data solutions for pharmaceutical and biotechnology companies, Symbiance is committed to innovative and precise results that will allow clients to bring drugs to market quickly, accurately and cost effectively. Symbiance includes a clinical data management unit, biostatistical analysis, and SAS programming divisions supporting Phase I through IV clinical trials. For more information, please visit www.symbiance.com.
"The BioClinica Certified Partner Program saw significant growth in 2010," continued Benton. "This growth has continued into the new year with the addition of experienced partners like Symbiance, allowing BioClinica to offer both a best in class product suite and added-value services for our clients. As many CROs seek partners that offer the highest level of technical expertise with global reach and support, they are finding that BioClinica fulfills their needs with the flexibility and capabilities that they require."
Follow BioClinica on the Trial Blazers blog at http://info.bioclinica.com/blog, and on twitter at http://twitter.com/bioclinica.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With over 20 years of experience and more than 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.